Article Details
Retrieved on: 2024-04-02 20:02:18
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Anti-CGRP monoclonal antibodies were superior to BoNT-A in reducing migraine-related headache days, disability, and mediation use at 6 and 12 ...
Article found on: www.clinicalpainadvisor.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here